SureNano Science Ltd (SURE) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 169.00
• Price to Earnings (P/E): ―
• Beta (1Y): 1.32
• Revenue Growth: N/A
• EPS Growth: 83.82%
• Country: CA
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 66
• Industry: Chemicals - Specialty
• EPS (TTM): >-0.01
• Shares Outstanding: 21,457,800
• 10 Day Avg. Volume: 308
• 30 Day Avg. Volume: 169
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 28 Underperform
• Price Target: ―

SureNano Science Ltd's stock score is significantly hindered by its poor financial performance, with no revenue generation and ongoing operational losses. The technical analysis offers little optimism as the stock shows no clear trend and is near oversold conditions. Valuation metrics are concerning, with a negative P/E ratio and no dividend yield. These factors collectively suggest a high-risk investment with limited upside potential.

SureNano Science Ltd Business Overview & Revenue Model

Company Description

SureNano Science Ltd (SURE) is a company focused on the development and commercialization of advanced nanotechnology solutions. Operating within the sectors of biotechnology and materials science, SureNano leverages cutting-edge research to create innovative products and applications that address challenges in various industries including healthcare, electronics, and environmental sustainability.

How the Company Makes Money

SureNano Science Ltd generates revenue through the commercialization of its proprietary nanotechnology solutions. Key revenue streams include the sale of nanomaterials and related products to industrial clients, licensing agreements for its patented technologies, and collaborative partnerships with other companies for joint development projects. The company may also receive funding from grants or research partnerships aimed at advancing nanotechnology applications. Significant partnerships with industry leaders or research institutions can enhance its market reach and contribute to its earnings.

SureNano Science Ltd Financial Statement Overview

Summary

SureNano Science Ltd is experiencing significant financial difficulties, with no revenue generation and continued operational losses. The balance sheet reflects financial instability with negative equity, despite having no debt. Persistent negative cash flows indicate ongoing challenges in sustaining operations and generating cash.

Income Statement

SureNano Science Ltd has consistently reported zero total revenue in recent periods, indicating a complete lack of sales activity. Gross profit, EBIT, and EBITDA margins are all negative, highlighting substantial operational losses. There is no revenue growth, further indicating challenges in business expansion or market penetration.

Balance Sheet

The company's balance sheet shows negative stockholders' equity, suggesting financial instability and potential insolvency risks. The absence of debt is a positive aspect, reducing leverage risks. However, substantial liabilities relative to assets and negative equity highlight severe financial distress.

Cash Flow

Operating and free cash flows are negative, indicating cash outflows due to operating activities without sufficient income. The operating cash flow to net income ratio is not meaningful due to negative figures. The lack of capital expenditures suggests limited investment in growth or future projects.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	0.00	0.00	0.00	0.00	18.00K	36.00K
Gross Profit	-1.88K	-2.50K	-2.50K	-3.75K	16.51K	34.66K
EBITDA	-239.47K	-57.09K	-277.39K	-380.27K	-1.12M	-81.59K
Net Income	-59.59K	-59.59K	-279.89K	-384.02K	-1.12M	-82.51K
Balance Sheet
Total Assets	54.27K	54.27K	153.11K	317.61K	686.44K	966.81K
Cash, Cash Equivalents and Short-Term Investments	23.49K	23.49K	134.80K	276.99K	667.09K	929.01K
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	134.04K	134.04K	173.29K	57.90K	36.49K	17.32K
Stockholders Equity	-79.77K	-79.77K	-20.18K	259.71K	649.95K	949.49K
Cash Flow
Free Cash Flow	-161.31K	-161.31K	-142.19K	-403.63K	-669.76K	-102.99K
Operating Cash Flow	-161.31K	-161.31K	-142.19K	-383.63K	-669.76K	-102.99K
Investing Cash Flow	0.00	0.00	0.00	-6.47K	0.00	0.00
Financing Cash Flow	50.00K	50.00K	0.00	0.00	407.85K	1.03M

SureNano Science Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:SURE, the sentiment is Negative. The current price of 0.1 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.14, and above the 200-day MA of 0.09, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.86 is Neutral, neither overbought nor oversold. The STOCH value of 28.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:SURE.

SureNano Science Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GMG	64 Neutral	C$91.36M	―	-72.52%	―	-9.37%	22.80%
Sector *	61 Neutral	$10.41B	7.18	-0.06%	2.87%	2.87%	-36.73%
HG	52 Neutral	C$445.64M	―	-87.47%	―	331.08%	15.77%
CNO	49 Neutral	C$15.26M	86.54	-86.10%	―	16.38%	-202.03%
IZ	45 Neutral	C$424.07K	100.00		―	109.13%	―
SURE	28 Underperform		―	167.59%	―	―	83.82%
GGG.H	―	C$540.14K	―		―	―	―